血管内皮生长因子B(VEGFB)多克隆抗体
Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
VEGF-B; VEGFL; VRF; VEGF-Related Factor
- 编号PAA144Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPA144Hu01-血管内皮生长因子B(VEGFB)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 浓度500µg/mL
- 且适物种Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，猪)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 569 ¥ 1327 ¥ 1896 ¥ 4740 ¥ 18960
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Vector Red staining on IHC-P; Samples: Human Placenta Tissue; Primary Ab: 20µg/ml Rabbit Anti-Human VEGFB Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
-
DAB staining on IHC-P;
Samples: Human Liver Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human VEGFB Antibody
Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human VEGFB Antibody
Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant VEGFB, Human.
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对VEGFB的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别VEGFB。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA144Hu01 | 血管内皮生长因子B(VEGFB)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA144Hu01 | 血管内皮生长因子B(VEGFB)活性蛋白 | Cell culture; Activity Assays. |
| PAA144Hu01 | 血管内皮生长因子B(VEGFB)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA144Hu71 | 血管内皮生长因子B(VEGFB)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAA144Hu81 | 血管内皮生长因子B(VEGFB)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| MAA144Hu22 | 血管内皮生长因子B(VEGFB)单克隆抗体 | WB; IHC; ICC; IP. |
| LAA144Hu82 | 血管内皮生长因子B(VEGFB)单克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA144Hu72 | 血管内皮生长因子B(VEGFB)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEA144Hu | 血管内皮生长因子B(VEGFB)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA144Hu | 血管内皮生长因子B(VEGFB)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| International Journal of Cardiology | Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. [PubMed: 22459379] |
| Applied Sciences-Basel | Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study [pubmed:29099033] |
| Journal of Endocrinological Investigation | Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell [10.1007/s40618-017-0677-z] |
| EXCLI Journal | Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction [] |
| Cancer Chemother Pharmacol | Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors [34164713] |
留言咨询